In addition, we found that the expression of PAKs in most tumors was distinctly higher than that in the corresponding normal tissues, while PAK1, PAK2 and PAK4 showed the most significant differences but only in Cholangiocarcinoma (CHOL) and Acute Myeloid Leukemia (LAML). This evidence concerns the gene PAK4 and acute myeloid leukemia.